How many benefit plans does Ipsen Biopharmaceuticals, Inc report on Form 5500?

Ipsen Biopharmaceuticals, Inc (EIN 26-0042539) reports 1 benefit plan(s) in the loaded Form 5500 dataset.

What is the EIN for Ipsen Biopharmaceuticals, Inc?

The Employer Identification Number (EIN) reported for Ipsen Biopharmaceuticals, Inc is 26-0042539.

What is the latest Form 5500 filing year for Ipsen Biopharmaceuticals, Inc?

The latest loaded Form 5500 filing year for Ipsen Biopharmaceuticals, Inc is 2023.

Ipsen Biopharmaceuticals, Inc — Form 5500 filings & benefit plans

Form 5500 plan sponsor summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Ipsen Biopharmaceuticals, Inc (EIN 26-0042539) is a plan sponsor located in Berkeley Heights, NJ with 1 reported benefit plan(s) in the loaded dataset. The latest loaded Form 5500 filing year is 2023.

Company overview (based on loaded 2023 public filings)

EIN: 26-0042539
Location: Berkeley Heights, NJ
Loaded plans: 2
Latest filing year: 2023

Reported financial aggregate (2023)

Reported net position

Total reported assets (EOY): $165,883,134
Total reported liabilities (EOY): $0
Total reported net assets (EOY): $165,883,134

Contributions & income

Employer contributions: $14,494,898
Participant contributions: $13,875,402
Total income / additions: $61,790,092

Expenses & distributions

Benefits paid / distributions: $20,818,373
Total expenses: $20,928,497
Net increase / (decrease): $40,861,595

Coverage

Total reported participants: 1,547
Plans with financial statements: 1
Plans with provider compensation: 1

Totals sum the latest loaded 2023 public Form 5500 filing per plan for this company's plans — one filing per plan, so multiple years are never double-counted. Figures are reported values from loaded Schedule H / I (and Schedule C for provider compensation); fields a plan did not report are treated as missing, not zero. These are not audited or official totals.

Largest loaded plans by reported assets

Ipsen Biopharmaceuticals, Inc plans by reported end-of-year assets
Plan	Plan #	Participants	Reported assets (EOY)	Year
Ipsen Biopharmaceuticals, Inc. U.S. 401(K) Plan	001	1,063	$165,883,134	2023
Ipsen Biopharmaceuticals, Inc.	501	484	not reported in the loaded dataset	2023

Search all 2 loaded plans for this company →

Latest loaded filings

Most recent loaded Form 5500 filings for Ipsen Biopharmaceuticals, Inc
Year	Plan	Participants	Schedules	Filing
2023	Ipsen Biopharmaceuticals, Inc.	484	—	20240726124027NAL0010207923001
2023	Ipsen Biopharmaceuticals, Inc. U.S. 401(K) Plan	1,063	H, C	20241004123137NAL0005694467001